These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35899617)

  • 21. P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use.
    Grotti S; Bolognese L
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e9-e12. PubMed ID: 29538137
    [No Abstract]   [Full Text] [Related]  

  • 22. Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Uhry S; Bessereau J; Camoin-Jau L; Paganelli F; Bonello L
    Hosp Pract (1995); 2012 Apr; 40(2):104-17. PubMed ID: 22615085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.
    Bhatt DL; Kaski JC; Delaney S; Alasnag M; Andreotti F; Angiolillo DJ; Ferro A; Gorog DA; Lorenzatti AJ; Mamas M; McNeil J; Nicolau JC; Steg PG; Tamargo J; Tan D; Valgimigli M
    Int J Cardiol; 2021 Aug; 337():1-8. PubMed ID: 34000356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y
    Sibbing D; Aradi D; Alexopoulos D; Ten Berg J; Bhatt DL; Bonello L; Collet JP; Cuisset T; Franchi F; Gross L; Gurbel P; Jeong YH; Mehran R; Moliterno DJ; Neumann FJ; Pereira NL; Price MJ; Sabatine MS; So DYF; Stone GW; Storey RF; Tantry U; Trenk D; Valgimigli M; Waksman R; Angiolillo DJ
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1521-1537. PubMed ID: 31202949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.
    Stimpfle F; Geisler T
    Pharmacogenomics; 2015; 16(5):493-9. PubMed ID: 25916521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.
    Paarup Dridi N; Johansson PI; Lønborg JT; Clemmensen P; Radu MD; Qayyum A; Pedersen F; Kollslid R; Helqvist S; Saunamäki K; Kelbæk H; Jørgensen E; Engstrøm T; Holmvang L
    Platelets; 2015; 26(6):521-9. PubMed ID: 25166751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.
    Brener SJ; Serruys PW; Morice MC; Mehran R; Kappetein AP; Sabik JF; Liu Y; Dressler O; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Oct; 72(17):2086-2087. PubMed ID: 30336833
    [No Abstract]   [Full Text] [Related]  

  • 28. Emerging oral antiplatelet therapies for acute coronary syndromes.
    Pollack CV
    Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects.
    Maggioni AP; Dondi L; Pedrini A; Ronconi G; Calabria S; Cimminiello C; Martini N
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):527-535. PubMed ID: 30209955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
    Qutub MA; Chong AY; So DY
    Can J Cardiol; 2015 Dec; 31(12):1481-4. PubMed ID: 26243350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
    Paravattil B; Elewa H
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy in acute coronary syndromes.
    Grove EL; Würtz M; Thomas MR; Kristensen SD
    Expert Opin Pharmacother; 2015; 16(14):2133-47. PubMed ID: 26293612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.
    Deharo P; Pons C; Pankert M; Bonnet G; Quilici J; Grosdidier C; Beguin S; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Int J Cardiol; 2013 Oct; 168(5):5004-5. PubMed ID: 23915522
    [No Abstract]   [Full Text] [Related]  

  • 35. De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Guo C; Li M; Lv YH; Zhang MB; Wang ZL
    Platelets; 2020; 31(1):15-25. PubMed ID: 30759033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention.
    Rollini F; Franchi F; Angiolillo DJ
    EuroIntervention; 2017 Feb; 12(14):1681-1683. PubMed ID: 28216470
    [No Abstract]   [Full Text] [Related]  

  • 37. Newer antiplatelet agents in acute coronary syndrome.
    Ferro A
    BMJ; 2016 Jan; 352():h7025. PubMed ID: 26742542
    [No Abstract]   [Full Text] [Related]  

  • 38. Clopidogrel or ticagrelor in elderly patients with acute coronary syndromes - Nihil nocere!
    Schäfer A
    Int J Cardiol; 2022 Apr; 352():19-20. PubMed ID: 35090985
    [No Abstract]   [Full Text] [Related]  

  • 39. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prasugrel in the treatment of acute coronary syndrome.
    Spartalis M; Tzatzaki E; Spartalis E; Paschou SA; Athanasiou A; Iliopoulos DC; Siasos G; Voudris V
    Future Cardiol; 2020 Nov; 16(6):559-568. PubMed ID: 32390477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.